Related Experiment Video
Updated: Jun 24, 2026

09:34
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Genome-based prediction of common diseases: methodological considerations for future research
A Cecile Jw Janssens1, Cornelia M van Duijn
1Department of Epidemiology, Erasmus University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands.
Genome Medicine
|April 4, 2009
Summary
Genome-based disease prediction is currently not informative for common conditions. Further research is needed to establish the clinical validity and utility of genetic testing for public health applications.
Area of Science:
- Genomics
- Public Health
- Clinical Medicine
Background:
- Translating genomic knowledge into clinical practice remains a significant challenge.
- Current genome-based predictions for common diseases like diabetes, heart disease, and cancer lack informativeness.
- Limited contribution of identified genetic susceptibility variants to multifactorial disease development.
Purpose of the Study:
- Critically appraise the usefulness of genome-based applications in clinical and public health.
- Propose a framework for evaluating the clinical validity and utility of genetic tests.
- Review studies on the predictive value of genetic profiling from a methodological standpoint.
Main Methods:
- Review of recent studies on genetic profiling predictive value.
- Methodological analysis focusing on study population, genetic profile construction, and prediction model validation.
- Assessment of clinical utility and calibration of prediction models.
Main Results:
- Discrepancy exists between limited predictive value of genetic profiles and their commercial availability.
- Identified susceptibility variants currently contribute marginally to disease development.
- Need for robust methodologies to evaluate genome-based applications.
Conclusions:
- A framework is necessary for designing and analyzing studies to evaluate genetic tests.
- Careful consideration of methodological issues is crucial for identifying useful genome-based applications.
- Implementation of validated genome-based applications in clinical and public health requires further research.
Related Concept Videos
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...

